Related Experiment Videos

Prospective randomized studies are needed to define the role of axillary lymph node dissection in primary breast

S D Costa, G von Minckwitz, J F Gauwerky

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology

|August 1, 1997

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Adjuvant T-DM1 versus trastuzumab in patients with residual invasive disease after neoadjuvant therapy for HER2-positive breast cancer: subgroup analyses from KATHERINE.

Annals of oncology : official journal of the European Society for Medical Oncology·2021

A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple-negative breast cancer: clinical results and biomarker analysis of GeparNuevo study.

Annals of oncology : official journal of the European Society for Medical Oncology·2019

Survival analysis of carboplatin added to an anthracycline/taxane-based neoadjuvant chemotherapy and HRD score as predictor of response-final results from GeparSixto.

Annals of oncology : official journal of the European Society for Medical Oncology·2018

Expression of Cyclin D1 protein in residual tumor after neoadjuvant chemotherapy for breast cancer.

Breast cancer research and treatment·2017

Ten-year results of intense dose-dense chemotherapy show superior survival compared with a conventional schedule in high-risk primary breast cancer: final results of AGO phase III iddEPC trial.

Annals of oncology : official journal of the European Society for Medical Oncology·2017

BRCA1-like profile is not significantly associated with survival benefit of non-myeloablative intensified chemotherapy in the GAIN randomized controlled trial.

Breast cancer research and treatment·2017

See all related articles